Comparison of MPN, JAK2 V617F-positive MPN, JAK2 V617F-negative patients versus controls also revealed no difference in genotype distribution and no association between the TERT rs2736100 polymorphism and MPN or JAK2 V617F-positive MPN (Table 2). This evidence concerns the gene JAK2 and myeloproliferative neoplasm.